Barclays PLC Pfizer Inc Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$27.7 - $31.39 $129 Million - $146 Million	-4,646,900 Reduced 94.14%	289,500 $8.38 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $125 Million - $146 Million	4,936,400 New	4,936,400 $138 Million
Q4 2023 Feb 15, 2024	BUY	$26.13 - $33.94 $13.3 Million - $17.3 Million	510,000 Added 182.14%	790,000 $22.7 Million
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $10.6 Million - $12.4 Million	-331,400 Reduced 54.2%	280,000 $9.29 Million
Q2 2023 Aug 03, 2023	BUY	$36.12 - $41.79 $1.88 Million - $2.17 Million	52,000 Added 9.3%	611,400 $22.4 Million
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $547,521 - $712,792	13,900 Added 2.55%	559,400 $22.8 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $22.8 Million - $29.7 Million	545,500 New	545,500 $28 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $5.37 Million - $6.37 Million	115,400 Added 178.64%	180,000 $9.44 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $9.9 Million - $14.7 Million	-239,600 Reduced 78.76%	64,600 $3.82 Million
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $13.5 Million - $17.4 Million	-345,200 Reduced 53.16%	304,200 $13.1 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $1.01 Million - $1.14 Million	28,000 Added 4.51%	649,400 $25.4 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $401,880 - $453,240	-12,000 Reduced 1.89%	621,400 $22.5 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $394,946 - $502,208	-11,800 Reduced 1.83%	633,400 $23.3 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $10.5 Million - $12.3 Million	331,500 Added 105.67%	645,200 $23.7 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $15 Million - $18.1 Million	-496,500 Reduced 61.28%	313,700 $10.3 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $710,889 - $1.02 Million	-26,300 Reduced 3.14%	810,200 $26.4 Million
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $888,840 - $1.01 Million	-27,000 Reduced 3.13%	836,500 $32.8 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $4.72 Million - $6.12 Million	-145,200 Reduced 14.39%	863,500 $31 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $9.33 Million - $10.5 Million	252,400 Added 33.37%	1,008,700 $43.7 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $1.61 Million - $1.77 Million	43,000 Added 6.03%	756,300 $32.1 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $4.97 Million - $5.67 Million	129,200 Added 22.12%	713,300 $31.1 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $2.16 Million - $2.62 Million	-62,600 Reduced 9.68%	584,100 $25.7 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $9.76 Million - $10.4 Million	-295,800 Reduced 31.38%	646,700 $23.5 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $14.9 Million - $17.2 Million	465,900 Added 97.75%	942,500 $33.4 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $5.99 Million - $6.36 Million	180,200 Added 60.8%	476,600 $17.3 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $9.19 Million - $10.1 Million	296,400	296,400 $10.6 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$10.7 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.33 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.13 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.29 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $142B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account